In
a recent eight week clinical study conducted at
the University of Connecticut, participants achieved
significant results when compared to the placebo
in the following areas:
- Weight Loss (70% greater results than placebo
test groups)
- Fat Loss (92% greater results than placebo
test groups)
- Body Composition Enhancement (121% greater
results than placebo test groups)
- Waist Circumference Reduction (62% greater
results than placebo test groups)
The influence of a proprietary
blend of high viscosity polysaccharides and esterified
fatty acids on adipocytokine and regional body
composition responses to a weight loss program
was examined. Twenty-two women (Supplement group
(S) (n=11): age= 36.8±7.2 y; weight=87.4
±6.1 kg; % body fat= 43.6±7.1);
Placebo group (P) (n=11): age = 38.3±6.8
y; weight = 88.3±7.2 kg; % body fat=44.2±8.2)
completed an 8-week placebo-controlled, double-blind
study consisting of a caloric restricted diet
and cardiovascular exercise. Body composition
and serum insulin, leptin, and adiponectin were
assessed at pre-, mid-, and post- intervention.
From pre- to post- intervention, significant decreases
(p<0.05) were observed for body weight (S:
87.4±6.1 to 78.2±3.4 kg; P: 88.3±7.2
to 82.9±4.1 kg) (p<0.05 S vs P), % body
fat (S: 43.6±7.1 to 36.2±4.4; P:
44.3±8.2 to 40.9±4.3) (p<0.05
S vs P), leptin (S: 28.2±6.1 to 16.3±3.4
µg·ml-1: 29.3±9.1 to 19.7±3.3
µg·ml-1) (p<0.05 S vs P), and
insulin (S: 7.2±2.2 to 5.4±2.4 mU·L-1;
P: 7.7±2.2 to 5.2±2.7 mU·L-1).
Serum adiponectin increased (p<0.05) (S: 12.2±3.1
to 26.2±3.4 µg·ml-1: 12.6±4.2
to 21.7±4.3 µg·ml-1) (p<0.05
for S vs P). Data indicated that supplementation
with a proprietary blend of high viscosity polysaccharides
and esterified fatty acids during an 8-week weight
loss program exhibited favorable effects on adipocytokines
and regional body composition.
- Unsuccessful attempts to modulate human obesity
have lead to many research attempts to understand
the neurological and hormonal pathways regulating
energy intake and energy expenditure
- Adipocytokines appear to play an important
role in the connection between the brain, adipose
tissue and other peripheral organs involved
in the weight regulatory pathway
- Weight loss programs combining dietary and
exercise lifestyle interventions behavior modification
and medication appear to be more effective than
any these strategies administered alone
To determine the effects of a proprietary blend
of high viscosity polysaccharides and esterified
fatty acids supplementation when combined with
an 8-week diet and exercise regimen in women who
were overweight on adiposity and adipocytokines
Participants: 22 healthy women
who were overweight Supplement Group (N= 11):
Age: 36.8±7.2 y; Height: 163.8±9.1cm
Placebo group (N= 11): Age: 38.3±6.8 y;
Height: 162.7±9.3 cm
Exercise: 30-60 minutes, 4-5
days/week at 60-90% of max HR Cycling, walking,
jogging
Diet: Moderately caloric restricted
diet of self-selected commercially available foods
in a free-living environment. Weekly nutritional
counseling meetings led by a registered dietician.
Supplement: 3 capsules at the
two largest meals each day (6 capsules per day)
Supplement = 400 mg of high viscosity polysaccharides
and Celadrin.
placebo = 400 mg of magnesium stearate per capsule)
Body Mass
Body Mass (kg) during the
8-week weight loss intervention for the supplement
and placebo groups. * = P < 0.05 from corresponding
Week 0 value. † = P < 0.05 from corresponding
Week 4 value. ‡ = P < 0.05 from corresponding
Placebo Group value
Body Composition

Body Composition (% Body Fat) during the 8-week
weight loss intervention for the supplement and
placebo groups. * = P < 0.05 from corresponding
Week 0 value. † = P <0.05 from corresponding
Week 4 value. ‡ = P < 0.05 from corresponding
Placebo Group value
Insulin

Circulating Insulin (mU/L) during the 8-week
weight loss intervention for the supplement and
placebo groups. * = P < 0.05 from corresponding
Week 0 value. † = P < 0.05 from corresponding
Week 4 value. ‡ = P < 0.05 from corresponding
Placebo Group value
Adiponectin

Circulating Adiponectin (µg/ml) during
the 8-week weight loss intervention for the supplement
and placebo groups. * = P < 0.05 from corresponding
Week 0 value. † = P < 0.05 from corresponding
Week 4 value. ‡ = P < 0.05 from corresponding
Placebo Group value
Leptin

Circulating Leptin (ng/ml) during the 8-week
weight loss intervention for the supplement and
placebo groups. * = P < 0.05 from corresponding
Week 0 value. † = P < 0.05 from corresponding
Week 4 value. ‡ = P < 0.05 from corresponding
Placebo Group value
Waist Circumference

Waist Circumference (cm) changes during the 8-week
weight loss intervention for the supplement and
placebo groups. * = P < 0.05 from corresponding
Week 0 value. † = P < 0.05 from corresponding
Week 4 value. ‡ = P < 0.05 from corresponding
Placebo Group value
Hip Circumference

Hip Circumference (cm) changes during the 8-week
weight loss intervention for the supplement and
placebo groups. * = P < 0.05 from corresponding
Week 0 value. † = P < 0.05 from corresponding
Week 4 value. ‡ = P < 0.05 from corresponding
Placebo Group value
Thigh Circumference

Thigh Circumference (cm) changes during the
8-week weight loss intervention for the supplement
and placebo groups. * = P < 0.05 from corresponding
Week 0 value. † = P < 0.05 from corresponding
Week 4 value. ‡ = P < 0.05 from corresponding
Placebo Group value
Both groups of women in the 8-week weight loss
program showed:
- Significant weight and fat loss
- Significant changes in circulating adipocytokine
concentrations
Women receiving the soluble polysaccharide dietary
supplement during the weight loss program showed:
- Greater weight loss
- Greater fat loss
- Greater effects on circulating adipocytokine
concentrations
|